Exploring the Science Behind Antimicrobial Products & Technologies

July 19, 2011

Manufacturers make claims about their products' efficacy in killing disease-causing pathogens, but what do infection preventionists really know about the validity of these claims? In a series of articles, we'll take a look at what practitioners in infection prevention should understand about the science behind label claims and marketing hype, including the FDA clearance and EPA registration processes, as well as testing protocols that preceded a product's appearance in the marketplace. In this first article, we talk to Wallace Puckett, PhD, vice president of science and technology for STERIS Corporation, about the knowledge gaps that currently exist relating to research and development of disinfectants, antibacterials, antimicrobials, microbicides and sporicides.

Manufacturers make claims about their products' efficacy in killing disease-causing pathogens, but what do infection preventionists really know about the validity of these claims? In a series of articles, we'll take a look at what practitioners in infection prevention should understand about the science behind label claims and marketing hype, including the FDA clearance and EPA registration processes, as well as testing protocols that preceded a product's appearance in the marketplace. In this first article, we talk to Wallace Puckett, PhD, vice president of science and technology for STERIS Corporation, about the knowledge gaps that currently exist relating to research and development of disinfectants, antibacterials, antimicrobials, microbicides and sporicides.